Human iPSC-based Drug Testing Platform for Muscular Dystrophy
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- THE JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland has been assigned a patent (No. US 12169196 B2, initially filed April 3, 2020) developed by three inventors Gabsang Lee, Baltimore, Maryland; Kathryn Wagner, Baltimore, Maryland; and Congshan Sun, Baltimore, Maryland, for "Human iPSC-based drug testing platform for muscular dystrophy." . . .